Exact Sciences (EXAS) Gains; Blue Cross Said to Classify Cologuard as Medically Necessary
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Exact Sciences (NASDAQ: EXAS) Gains; Blue Cross Said to Classify Cologuard as Medically Necessary
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toshiba considering spinning off semiconductor operations and selling a stake to Western Digital (WDC) - Nikkei
- U.S. Bancorp (USB) call put ratio 4.5 calls to 1 put into Q4
- Stocks with Implied Volatility Movement
Create E-mail Alert Related CategoriesRumors, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!